{
    "2020-08-04": [
        [
            {
                "time": "2021-08-03",
                "original_text": "A股融资融券日报：两融余额增加245.57亿元（8月3日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "增加",
                        "A股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-04",
                "original_text": "智飞生物：业绩保持强劲增长 代理品种需求旺盛",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "业绩",
                        "增长",
                        "代理品种",
                        "需求"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-04",
                "original_text": "智飞生物中报点评：Q2略超预期，新冠疫苗处于国内第一梯队！【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "中报",
                        "新冠疫苗",
                        "第一梯队"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-04",
                "original_text": "医药生物行业报告：疫情后周期拥抱医药新基建和大消费 重点关注疫苗赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "疫情",
                        "疫苗",
                        "新基建",
                        "大消费"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-04",
                "original_text": "年内6只基金收益率翻倍，均为医药医疗主题基金",
                "features": {
                    "keywords": [
                        "基金",
                        "收益率",
                        "翻倍",
                        "医药医疗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-04",
                "original_text": "自研产品和代理疫苗销售齐升 智飞生物上半年净利增超三成",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "自研产品",
                        "代理疫苗",
                        "净利",
                        "增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-04",
                "original_text": "医药行业周报：疫情板块持续获得市场高关注度 继续关注中报业绩突出公司",
                "features": {
                    "keywords": [
                        "医药行业",
                        "疫情",
                        "板块",
                        "市场",
                        "关注度",
                        "中报业绩"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}